Cencora, Inc.
0HF3.L
London Stock Exchange305.92
USD
+8.20
- -
Cencora, Inc.
0HF3.L
(London Stock Exchange)
Recent
price
305.92
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Cencora, formerly known as AmerisourceBergen Corporation, operates as a global pharmaceutical sourcing and distribution services company. It specializes in the distribution of pharmaceutical products, including brand-name and generic pharmaceuticals, over-the-counter healthcare products, and related medical supplies. The company also provides comprehensive pharmacy and healthcare services such as consulting, logistics, and specialty pharmaceutical distribution. Core product and service categories include pharmaceutical distribution; specialty pharmaceuticals; consulting and management services for pharmacies and healthcare providers; and patient support programs. Cencora serves a variety of sectors including healthcare providers, pharmaceutical manufacturers, and pharmacies across North America and internationally. It operates through a network that supports the efficient delivery and availability of pharmaceutical products to healthcare systems and patients. The company was founded in 2001 and is headquartered in Conshohocken, Pennsylvania, United States. Recent major changes for Cencora include its rebranding from AmerisourceBergen to Cencora in 2024, reflecting a strategic evolution in its business model toward broader healthcare services and global expansion. The company has focused on enhancing its specialty pharmaceutical capabilities and expanding its services in high-growth healthcare segments. It actively pursues strategic partnerships and acquisitions to strengthen its position as a critical link in the pharmaceutical supply chain and value-added services, driving innovation in pharmaceutical distribution and patient care support. Cencora operates primarily in the pharmaceutical distribution industry, targeting healthcare providers, pharmacies, and pharmaceutical manufacturers. Its global footprint and integrated service offerings position it as a pivotal player in the healthcare supply chain, delivering a mix of products and value-added services aimed at improving access to medications and healthcare outcomes worldwide.